GRAS status and approval from Health Canada complement emerging science on the benefits of this potential testosterone booster.
HP Ingredients (Bradenton, FL) is improving global recognition for its tongkat ali (Eurycoma longifolia) extract, with self-affirmed U.S. GRAS status and approval from Health Canada. The company made its announcement at November's SupplySide West tradeshow in Las Vegas.
The gnarling root is more familiar to Asian cultures, and its history of use apparently dates back as much as 4000 years, with proof found in ancient Chinese texts. Tongkat ali is sought for its adaptogenic qualities and its innate ability to increase free testosterone levels in those who consume it. HP Ingredients CEO Annie Eng says her company’s LJ100 tongkat ali extract has, time and time again, shown the ability to increase testosterone levels in men and women while also reducing cortisol levels (a key market of stress) and without affecting estrogen. Compared to steroids which can create new testosterone in the body, science suggests that tongkat ali actually frees up testosterone that is bound within the body. Lower signs of sex hormone-binding globulin (SHBG) support this notion.
Health benefits of free testosterone, beyond sex health, are many, and HP Ingredients is so far already exploring weight management potential. Eng says the next several years of research will offer more insight.
LJ100 is a freeze-dried water extract of tongkat ali, and it’s standardized for 40% glycol saponins. This very extract is the source material for many published clinical trials on the ingredient, which is classified by the World Health Organization as having no toxicity.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.